{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T18:23:41Z","timestamp":1790015021985,"version":"4.0.1"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2012,10,25]],"date-time":"2012-10-25T00:00:00Z","timestamp":1351123200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur J Drug Metab Pharmacokinet"],"published-print":{"date-parts":[[2013,6]]},"DOI":"10.1007\/s13318-012-0107-8","type":"journal-article","created":{"date-parts":[[2012,10,24]],"date-time":"2012-10-24T14:39:40Z","timestamp":1351089580000},"page":"115-121","source":"Crossref","is-referenced-by-count":17,"title":["Population pharmacokinetics of digoxin in elderly patients"],"prefix":"10.1007","volume":"38","author":[{"given":"Rong","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Su-lan","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming-li","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun-yan","family":"Qian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zong-ling","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,10,25]]},"reference":[{"key":"107_CR1","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1097\/00007691-199602000-00008","volume":"18","author":"LA Bauer","year":"1996","unstructured":"Bauer LA, Horn JR, Pettit H (1996) Mixed-effect modeling for detection and evaluation of drug interactions: digoxin-quinidine and digoxin-verapamil combinations. Ther Drug Monit 18:46\u201352","journal-title":"Ther Drug Monit"},{"key":"107_CR2","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1007\/s00228-009-0698-4","volume":"65","author":"AL Chan","year":"2009","unstructured":"Chan AL, Wang MT, Su CY, Tsai FH (2009) Risk of digoxin intoxication caused by clarithromycin-digoxin interactions in heart failure patients: a population-based study. Eur J Clin Pharmacol 65:1237\u20131243","journal-title":"Eur J Clin Pharmacol"},{"key":"107_CR3","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1592\/phco.27.3.472","volume":"27","author":"KJ DeVore","year":"2007","unstructured":"DeVore KJ, Hobbs RA (2007) Plasma digoxin concentration fluctuations associated with timing of plasma sampling and amiodarone administration. Pharmacotherapy 27:472\u2013475","journal-title":"Pharmacotherapy"},{"key":"107_CR4","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1097\/00045391-200211000-00006","volume":"9","author":"ES EL Desoky","year":"2002","unstructured":"EL Desoky ES, Nagaraja NV, Derendorf H (2002) Population pharmacokinetics of digoxin in Egyptian pediatric patients: impact of one data point utilization. Am J Ther 9:492\u2013498","journal-title":"Am J Ther"},{"key":"107_CR5","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1111\/j.1751-7176.2011.00513.x","volume":"13","author":"WJ Elliott","year":"2011","unstructured":"Elliott WJ, Ram CV (2011) Calcium channel blockers. J Clin Hypertens (Greenwich) 13:687\u2013689","journal-title":"J Clin Hypertens (Greenwich)"},{"key":"107_CR6","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.amjopharm.2011.10.004","volume":"9","author":"LE Hines","year":"2011","unstructured":"Hines LE, Murphy JE (2011) Potentially harmful drug\u2013drug interactions in the elderly: a review. Am J Geriatr Pharmacother 9:364\u2013377","journal-title":"Am J Geriatr Pharmacother"},{"key":"107_CR7","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1007\/s00228-002-0553-3","volume":"58","author":"B Hornestam","year":"2003","unstructured":"Hornestam B, Jerling M, Karlsson MO, Held P, D.A.T. Group (2003) Intravenously administered digoxin in patients with acute atrial fibrillation: a population pharmacokinetic\/pharmacodynamic analysis based on the digitalis in acute atrial fibrillation trial. Eur J Clin Pharmacol 58:747\u2013755","journal-title":"Eur J Clin Pharmacol"},{"key":"107_CR8","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1007\/BF01113502","volume":"21","author":"MO Karlsson","year":"1993","unstructured":"Karlsson MO, Sheiner LB (1993) The importance of modeling interoccasion variability in population pharmacokinetic analyses. J Pharmacokinet Biopharm 21:735\u2013750","journal-title":"J Pharmacokinet Biopharm"},{"key":"107_CR9","first-page":"549","volume":"15","author":"F Keller","year":"1977","unstructured":"Keller F, Rietbrock N (1977) Bioavailability of digoxin: some pitfalls and problems. Int J Clin Pharmacol Biopharm 15:549\u2013556","journal-title":"Int J Clin Pharmacol Biopharm"},{"key":"107_CR10","first-page":"24","volume":"34","author":"E Krusteva","year":"1992","unstructured":"Krusteva E (1992) Changes in the plasma levels and basic pharmacokinetic parameters of digoxin used in combination with gentamicin, amiodarone and spironolactone. Folia Med (Plovdiv) 34:24\u201328","journal-title":"Folia Med (Plovdiv)"},{"key":"107_CR11","first-page":"107","volume":"59","author":"M Kurzawski","year":"2007","unstructured":"Kurzawski M, Bartnicka L, Florczak M, Gornik W, Drozdzik M (2007) Impact of ABCB1 (MDR1) gene polymorphism and P-glycoprotein inhibitors on digoxin serum concentration in congestive heart failure patients. Pharmacol Rep 59:107\u2013111","journal-title":"Pharmacol Rep"},{"key":"107_CR12","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1345\/aph.19103","volume":"34","author":"T Miura","year":"2000","unstructured":"Miura T, Kojima R, Sugiura Y, Mizutani M, Takatsu F, Suzuki Y (2000) Effect of aging on the incidence of digoxin toxicity. Ann Pharmacother 34:427\u2013432","journal-title":"Ann Pharmacother"},{"key":"107_CR13","first-page":"613","volume":"74","author":"SA Morris","year":"2006","unstructured":"Morris SA, Hatcher HF, Reddy DK (2006) Digoxin therapy for heart failure: an update. Am Fam Physician 74:613\u2013618","journal-title":"Am Fam Physician"},{"key":"107_CR14","doi-asserted-by":"crossref","first-page":"291","DOI":"10.5414\/CPP38291","volume":"38","author":"NV Nagaraja","year":"2000","unstructured":"Nagaraja NV, Park YJ, Jeon S, Sands CD, Derendorf H (2000) Population pharmacokinetics of digoxin in Korean patients. Int J Clin Pharmacol Ther 38:291\u2013297","journal-title":"Int J Clin Pharmacol Ther"},{"key":"107_CR15","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S0169-2607(98)00098-4","volume":"59","author":"J Parke","year":"1999","unstructured":"Parke J, Holford NH, Charles BG (1999) A procedure for generating bootstrap samples for the validation of nonlinear mixed-effects population models. Comput Methods Programs Biomed 59:19\u201329","journal-title":"Comput Methods Programs Biomed"},{"key":"107_CR16","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1007\/BF01060893","volume":"9","author":"LB Sheiner","year":"1981","unstructured":"Sheiner LB, Beal SL (1981) Some suggestions for measuring predictive performance. J Pharmacokinet Biopharm 9:503\u2013512","journal-title":"J Pharmacokinet Biopharm"},{"key":"107_CR17","doi-asserted-by":"crossref","first-page":"917","DOI":"10.7326\/0003-4819-138-11-200306030-00013","volume":"138","author":"MG Shlipak","year":"2003","unstructured":"Shlipak MG (2003) Pharmacotherapy for heart failure in patients with renal insufficiency. Ann Intern Med 138:917\u2013924","journal-title":"Ann Intern Med"},{"key":"107_CR18","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1016\/S0024-3205(01)01494-1","volume":"70","author":"K Takara","year":"2002","unstructured":"Takara K, Kakumoto M, Tanigawara Y, Funakoshi J, Sakaeda T, Okumura K (2002) Interaction of digoxin with antihypertensive drugs via MDR1. Life Sci 70:1491\u20131500","journal-title":"Life Sci"},{"key":"107_CR19","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1016\/S0022-3565(25)10423-0","volume":"263","author":"Y Tanigawara","year":"1992","unstructured":"Tanigawara Y, Okamura N, Hirai M, Yasuhara M, Ueda K, Kioka N, Komano T, Hori R (1992) Transport of digoxin by human P-glycoprotein expressed in a porcine kidney epithelial cell line (LLC-PK1). J Pharmacol Exp Ther 263:840\u2013845","journal-title":"J Pharmacol Exp Ther"},{"key":"107_CR20","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1007\/BF01059771","volume":"21","author":"JR Wade","year":"1993","unstructured":"Wade JR, Kelman AW, Howie CA, Whiting B (1993) Effect of misspecification of the absorption process on subsequent parameter estimation in population analysis. J Pharmacokinet Biopharm 21:209\u2013222","journal-title":"J Pharmacokinet Biopharm"},{"key":"107_CR21","doi-asserted-by":"crossref","first-page":"773","DOI":"10.2165\/00003088-200140100-00005","volume":"40","author":"E Yukawa","year":"2001","unstructured":"Yukawa E, Suematu F, Yukawa M, Minemoto M, Ohdo S, Higuchi S, Goto Y, Aoyama T (2001) Population pharmacokinetics of digoxin in Japanese patients: a 2-compartment pharmacokinetic model. Clin Pharmacokinet 40:773\u2013781","journal-title":"Clin Pharmacokinet"},{"key":"107_CR22","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1177\/0091270010374475","volume":"51","author":"M Yukawa","year":"2011","unstructured":"Yukawa M, Yukawa E, Suematsu F, Takiguchi T, Ikeda H, Aki H, Mimemoto M (2011a) Population pharmacokinetic investigation of digoxin in Japanese infants and young children. J Clin Pharmacol 51:857\u2013863","journal-title":"J Clin Pharmacol"},{"key":"107_CR23","doi-asserted-by":"crossref","first-page":"831","DOI":"10.2165\/11594230-000000000-00000","volume":"28","author":"M Yukawa","year":"2011","unstructured":"Yukawa M, Yukawa E, Suematsu F, Takiguchi T, Ikeda H, Aki H, Mimemoto M (2011b) Determination of digoxin clearance in Japanese elderly patients for optimization of drug therapy: a population pharmacokinetics analysis using nonlinear mixed-effects modelling. Drugs Aging 28:831\u2013841","journal-title":"Drugs Aging"}],"container-title":["European Journal of Drug Metabolism and Pharmacokinetics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13318-012-0107-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s13318-012-0107-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13318-012-0107-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,19]],"date-time":"2025-04-19T15:49:53Z","timestamp":1745077793000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s13318-012-0107-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,10,25]]},"references-count":23,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013,6]]}},"alternative-id":["107"],"URL":"https:\/\/doi.org\/10.1007\/s13318-012-0107-8","relation":{},"ISSN":["0378-7966","2107-0180"],"issn-type":[{"value":"0378-7966","type":"print"},{"value":"2107-0180","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,10,25]]}}}